망막정맥폐쇄증 치료 시장 규모, 점유율, 성장 분석 : 질환 유형별, 치료 유형별, 투약 유형별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Retinal Vein Occlusion Treatment Market Size, Share, and Growth Analysis, By Disease Type (Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion ), By Treatment Type, By Medication Type, By End-user, By Region - Industry Forecast 2025-2032
상품코드:1663091
리서치사:SkyQuest
발행일:2025년 02월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
망막정맥폐쇄증 치료제 시장 규모는 2023년 24억 3,000만 달러로 평가되었습니다. 2024년 25억 9,000만 달러에서 2032년에는 42억 5,000만 달러로 확대될 것으로 예상되며, 예측 기간(2025-2032년) 동안 6.4%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.
망막정맥폐쇄증(RVO) 치료 시장은 RVO의 유병률 증가와 이 질환에 취약한 인구의 고령화에 힘입어 크게 성장하고 있습니다. 망막혈관질환 중 하나인 RVO는 치료하지 않으면 시력 장애를 초래할 수 있습니다. 이 시장에서는 약물 요법, 레이저 요법, 수술 요법 등 주로 혈액순환 개선과 황반부종 완화에 중점을 둔 다양한 솔루션이 제공되고 있습니다. 항VEGF 약물은 비정상적인 혈관 발달을 관리하기 위해 특히 선호되고 있습니다. 북미와 유럽과 같은 지역은 선진화된 의료 시스템으로 인해 시장 확대를 주도하고 있으며, 아시아태평양은 의료에 대한 인식이 높아짐에 따라 빠르게 부상하고 있습니다. 지속적인 연구 투자, 혁신적인 진단 방법, 개인화된 치료 접근 방식은 시장 성장을 더욱 촉진하고 환자 치료 및 치료 결과를 향상시킬 것입니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
사례 연구
규제 상황
특허 분석
망막정맥폐쇄증 치료 시장 규모 : 질환 유형별&CAGR(2025-2032년)
시장 개요
망막중심 정맥 폐쇄(CRVO)
망막정맥 분지 폐쇄(BRVO)
망막정맥폐쇄증 치료 시장 규모 : 치료 유형별&CAGR(2025-2032년)
시장 개요
항VEGF
코르티코스테로이드
레이저 치료
망막정맥폐쇄증 치료 시장 규모 : 투약 유형별&CAGR(2025-2032년)
시장 개요
브랜드
제네릭
망막정맥폐쇄증 치료 시장 규모 : 최종사용자별&CAGR(2025-2032년)
시장 개요
병원
안과 클리닉
외래수술센터(ASC)
소매 약국
망막정맥폐쇄증 치료 시장 규모 : 지역별&CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
전년대비 매출 비교(2022-2024년)
주요 기업 개요
AbbVie Inc.(USA)
Roche(Switzerland)
Regeneron Pharmaceuticals, Inc.(USA)
Novartis AG(Switzerland)
Bayer AG(Germany)
Alimera Sciences(USA)
Aerie Pharmaceuticals, Inc.(USA)
Kodiak Sciences Inc.(USA)
Chugai Pharmaceutical Co., Ltd.(Japan)
Taiwan Liposome Company, Ltd.(Taiwan)
Graybug Vision, Inc.(USA)
Pfizer Inc.(USA)
IRIDEX Corporation(USA)
Lumenis(Israel)
Nidek Co., Ltd.(Japan)
Annexin Pharmaceuticals AB(Sweden)
Outlook Therapeutics, Inc.(USA)
CalciMedica Inc.(USA)
F. Hoffmann-La Roche AG(Switzerland)
Samsung Bioepis(South Korea)
결론과 제안
LSH
영문 목차
영문목차
Retinal Vein Occlusion Treatment Market size was valued at USD 2.43 billion in 2023 and is poised to grow from USD 2.59 billion in 2024 to USD 4.25 billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).
The retinal vein occlusion (RVO) treatment market is experiencing significant growth, fueled by the rising prevalence of RVO and an aging population susceptible to this disorder. RVO, a prevalent retinal vascular issue, can lead to vision impairment if untreated. The market offers a variety of solutions, including medications, laser therapy, and surgical options, primarily focusing on enhancing blood circulation and reducing macular edema. Anti-VEGF medications are particularly favored for managing abnormal blood vessel development. Regions like North America and Europe lead in market expansion due to advanced healthcare systems, while the Asia-Pacific region is rapidly emerging, driven by increased healthcare awareness. Continuous research investment, innovative diagnostics, and personalized treatment approaches are set to further propel market growth, enhancing patient care and outcomes.
Top-down and bottom-up approaches were used to estimate and validate the size of the Retinal Vein Occlusion Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Retinal Vein Occlusion Treatment Market is segmented by Disease Type, Treatment Type, Medication Type, End-user and region. Based on Disease Type, the market is segmented into Central Retinal Vein Occlusion (CRVO) and Branch Retinal Vein Occlusion (BRVO). Based on Treatment Type, the market is segmented into Anti-VEGF, Corticosteroid Drugs and Laser Therapy. Based on Medication Type, the market is segmented into Branded and Generics. Based on End-user, the market is segmented into Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers (ASC) and Retail Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Retinal Vein Occlusion Treatment Market
The market for retinal vein occlusion treatment is propelled by various influential factors, including the increasing prevalence of eye disorders worldwide, a rising elderly demographic, enhanced comprehension of ocular conditions, and the expansion of healthcare infrastructures. Additionally, technological innovations and the development of new therapies significantly boost market growth. The existence of a strong drug pipeline, along with recent drug approvals, plays a vital role in this upward trend. As cases of retinal vein occlusion continue to surge and research on effective treatments intensifies, there is potential for significant market expansion, opening avenues for the adoption of cutting-edge therapeutic solutions for this condition.
Restraints in the Retinal Vein Occlusion Treatment Market
The Retinal Vein Occlusion Treatment market encounters a significant challenge due to a lack of long-term clinical evidence. The effectiveness and safety of various treatment options compared to conventional therapies require more comprehensive evaluation. This uncertainty can hinder the adoption of newer therapies, as both healthcare professionals and patients may be hesitant to embrace treatments that lack robust, long-term studies. Furthermore, the dependence on existing treatments may continue as practitioners seek reassurance about the outcomes of emerging options. Consequently, addressing this restraint is essential for promoting growth and acceptance within the Retinal Vein Occlusion Treatment market.
Market Trends of the Retinal Vein Occlusion Treatment Market
The Retinal Vein Occlusion Treatment market is witnessing significant growth, primarily fueled by the rising prevalence of the condition among the aging population. As more individuals enter older age brackets, the incidence of retinal vein occlusion is expected to increase, necessitating innovative and effective treatment options. This trend is prompting healthcare providers and pharmaceutical companies to develop advanced therapies, including anti-VEGF injections and laser treatments, to cater to the growing patient demographic. As awareness and diagnosis improve, coupled with advancements in treatment modalities, the market is set to expand further, offering lucrative opportunities for stakeholders in the ophthalmology sector.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis
Global Retinal Vein Occlusion Treatment Market Size by Disease Type & CAGR (2025-2032)
Market Overview
Central Retinal Vein Occlusion (CRVO)
Branch Retinal Vein Occlusion (BRVO)
Global Retinal Vein Occlusion Treatment Market Size by Treatment Type & CAGR (2025-2032)
Market Overview
Anti-VEGF
Corticosteroid Drugs
Laser Therapy
Global Retinal Vein Occlusion Treatment Market Size by Medication Type & CAGR (2025-2032)
Market Overview
Branded
Generics
Global Retinal Vein Occlusion Treatment Market Size by End-user & CAGR (2025-2032)
Market Overview
Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers (ASC)
Retail Pharmacies
Global Retinal Vein Occlusion Treatment Market Size & CAGR (2025-2032)
North America (Disease Type, Treatment Type, Medication Type, End-user)
US
Canada
Europe (Disease Type, Treatment Type, Medication Type, End-user)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Disease Type, Treatment Type, Medication Type, End-user)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Disease Type, Treatment Type, Medication Type, End-user)
Brazil
Rest of Latin America
Middle East & Africa (Disease Type, Treatment Type, Medication Type, End-user)
